The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia

Schizophrenia Research

Volumn 161, Issue 1, 2015, Pages 113-118

  Pasternak, Ofer ^a   Westin, Carl Fredrik ^a   Dahlben, Brian ^a   Bouix, Sylvain ^a   Kubicki, Marek ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Degeneration; Free water; Neuroinflammation; Schizophrenia; White matter

Indexed keywords

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; EXTRACELLULAR SPACE; FRACTIONAL ANISOTROPY; HUMAN; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NUCLEAR MAGNETIC RESONANCE SCANNER; SCHIZOPHRENIA; WHITE MATTER LESION; ANISOTROPY; BRAIN MAPPING; CHRONIC DISEASE; COMPLICATION; ENCEPHALITIS; FEMALE; IMAGE PROCESSING; MALE; MIDDLE AGED; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; STATISTICS; WHITE MATTER;

ADULT; ANISOTROPY; BRAIN MAPPING; CHRONIC DISEASE; DIFFUSION MAGNETIC RESONANCE IMAGING; ENCEPHALITIS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; STATISTICS AS TOPIC; WHITE MATTER;

EID: 84920657751     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.07.031     Document Type: Article

References (30)

1. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) 1983, The University of Iowa, Iowa City, IA.
2. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) 1984, The University of Iowa, Iowa City, IA.
3. Basser P.J., Mattiello J., LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys. J. 1994, 66(1):259-267.
4. Davis K.L., Stewart D.G., Friedman J.I., Buchsbaum M., Harvey P.D., Hof P.R., Buxbaum J., Haroutunian V. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 2003, 60(5):443-456.
5. Dickerson F., Stallings C., Origoni A., Khushalani S., Yang S., Yolken R. C-reactive protein is elevated in schizophrenia. Schizophr. Res. 2012, 143(1):198-202.
6. Ellison-Wright I., Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr. Res. 2009, 108(1-3):3-10.
7. Fillman S.G., Cloonan N., Catts V.S., Miller L.C., Wong J., McCrossin T., Cairns M., Weickert C.S. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol. Psychiatry 2013, 18(2):206-214.
8. Fitzsimmons J., Kubicki M., Shenton M.E. Review of functional and anatomical brain connectivity findings in schizophrenia. Curr. Opin. Psychiatry 2013, 26(2):172-187.
9. Gur R.E., Gur R.C. Functional magnetic resonance imaging in schizophrenia. Dialogues Clin. Neurosci. 2010, 12(3):333-343.
10. Honea R., Crow T.J., Passingham D., Mackay C.E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry 2005, 162(12):2233-2245.
11. Kandel E., Schwartz J., Jessell T., Siegelbaum S., Hudspeth A.J. Principles of Neural Science 2013, McGraw-Hill Education. Fifth edition.
12. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
13. Keshavan M.S. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J. Psychiatr. Res. 1999, 33(6):513-521.
14. Kubicki M., McCarley R., Westin C.F., Park H.J., Maier S., Kikinis R., Jolesz F.A., Shenton M.E. A review of diffusion tensor imaging studies in schizophrenia. J. Psychiatr. Res. 2007, 41(1-2):15-30.
15. Lieberman J.A. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry 1999, 46(6):729-739.
16. Melonakos E.D., Shenton M.E., Rathi Y., Terry D.P., Bouix S., Kubicki M. Voxel-based morphometry (VBM) studies in schizophrenia-can white matter changes be reliably detected with VBM?. Psychiatry Res. 2011, 193(2):65-70.
17. Metzler-Baddeley C., O'Sullivan M.J., Bells S., Pasternak O., Jones D.K. How and how not to correct for CSF-contamination in diffusion MRI. NeuroImage 2012, 59(2):1394-1403.
18. Mori S., Wakana S., van Zijl P.C.M., Nagae-Poetscher L.M. MRI Atlas of Human White Matter 2005, Elsevier, Amsterdam, The Netherlands. 1st edition.
19. Najjar S., Pearlman D.M. Neuroinflammation and white matter pathology in schizophrenia: a systematic review. Schizophr. Res. 2014, 161:101-111.
20. Najjar S., Pearlman D.M., Alper K., Najjar A., Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflammation 2013, 10:43.
21. Pasternak O., Sochen N., Gur Y., Intrator N., Assaf Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 2009, 62(3):717-730.
22. Pasternak O., Westin C.F., Bouix S., Seidman L.J., Goldstein J.M., Woo T.U., Petryshen T.L., Mesholam-Gately R.I., McCarley R.W., Kikinis R., Shenton M.E., Kubicki M. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J. Neurosci. 2012, 32(48):17365-17372.
23. Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 2009, 44(1):83-98.
24. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., Behrens T.E. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 2006, 31(4):1487-1505.
25. Sommer I.E., de Witte L., Begemann M., Kahn R.S. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J. Clin. Psychiatry 2012, 73(4):414-419.
26. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., Bernstein H.G., Bogerts B. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 2008, 42(2):151-157.
27. Streit W.J. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006, 29(9):506-510.
28. Uranova N.A., Vikhreva O.V., Rachmanova V.I., Orlovskaya D.D. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr. Res. Treatment 2011, 2011:325789.
29. Voineskos A.N., Foussias G., Lerch J., Felsky D., Remington G., Rajji T.K., Lobaugh N., Pollock B.G., Mulsant B.H. Neuroimaging evidence for the deficit subtype of schizophrenia. JAMA Psychiatry 2013, 70(5):472-480.
30. Whitney N.P., Eidem T.M., Peng H., Huang Y., Zheng J.C. Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J. Neurochem. 2009, 108(6):1343-1359.